Single use system for sterilely producing lipid-nucleic acid particles
What is described is a process of forming lipid-nucleic acid nanoparticles simply and reproducibly under aseptic conditions comprising single use components.
1. A system for sterilely preparing a lipid-nucleic acid nanoparticle, comprising:
a 1 st holding unit for holding an organic lipid solution comprising lipids in a water-miscible organic solvent, wherein the 1 st holding unit comprises an inlet opening for receiving the organic lipid solution and an exit port for delivering the organic lipid solution;
a 2 nd holding unit for holding an aqueous solution comprising an RNA molecule, wherein the 2 nd holding unit comprises an inlet opening for receiving the aqueous solution and an exit port for delivering the aqueous solution;
a mixing unit for mixing the organic lipid solution and the aqueous solution to produce a fluid mixture, wherein the mixing unit comprises a first inlet opening for receiving the organic lipid solution by a 1 st connection from the 1 st holding unit to the mixing unit, a second inlet opening for receiving the aqueous solution by a 2 nd connection from the 2 nd holding unit to the mixing unit, and an exit port for delivering the fluid mixture;
a 3 rd holding unit for holding an aqueous buffer, wherein the 3 rd holding unit comprises an inlet opening for receiving the aqueous buffer and an exit port for delivering the aqueous buffer;
a dilution unit for diluting the fluid mixture with the aqueous buffer to produce a diluted fluid mixture, wherein the dilution unit comprises a 1 st inlet opening for receiving the aqueous buffer by a 3 rd connection from the 3 rd holding unit to the dilution unit, a 2 nd inlet opening for receiving the fluid mixture by a 4 th connection from the mixing unit to the dilution unit, and an exit port for delivering the diluted fluid mixture;
a concentrating unit comprising a transflow filter for concentrating and removing the organic solvent from the diluted fluid mixture to produce a filter retentate, wherein the concentrating unit comprises an inlet opening for receiving the diluted fluid mixture by a 5 th connection from the dilution unit to the concentrating unit, and an exit port for delivering the filter retentate; and
a vessel for collecting the filter retentate, wherein the vessel comprises an inlet opening for receiving the filter retentate by a 6 th connection from the concentration unit to the vessel and an exit port for delivery of the filter retentate;
wherein the system consists of components that are sterilized and disposable so as to be adapted for single batch usage.
2. The system of claim 1 , further comprising a preparation unit for preparing the organic lipid solution, wherein the preparation unit comprises an inlet opening for receiving an organic solvent and lipids, and an exit port for delivering the organic lipid solution by a 7 th connection from the preparation unit to the 1 st holding unit.
3. The system of claim 2 , wherein the 7 th connection comprises a 6 th pump for delivering the organic lipid solution from the preparation unit to the 1 st holding unit, and 1 st 0.45 micron or 0.1 micron filter for sterilizing the organic lipid solution.
4. The system of claim 1 , wherein the organic lipid solution, the aqueous solution, the fluid mixture, the diluted fluid mixture, and the filter retentate are sterile.
5. The system of claim 1 , wherein
the 1 st connection comprises a 1 st pump for delivering the organic lipid solution from the 1st holding unit to the mixing unit,
the 2 nd connection comprises a 2 nd pump for delivering the aqueous solution from the 2 nd holding unit to the mixing unit,
the 3 rd connection comprises a 3 rd pump for delivering the aqueous buffer from the 3rd holding unit to the dilution unit, and a 2 nd 0.45 micron or 0.1 micron filter for filtering the aqueous buffer;
the 4 th connection comprises a 4 th pump for delivering the fluid mixture from the mixing unit to the dilution unit; and
the 5 th connection comprises a 5 th pump for delivering the diluted fluid mixture from the dilution unit to the concentrating unit.
6. The system of claim 1 , wherein the lipids comprise a cationic lipid, a helper lipid, a sterol, and a polyethylene (PEG)-lipid conjugate.
7. The system of claim 1 , wherein the lipids further comprise a targeting lipid.
8. The system of claim 1 , wherein the RNA is a dsRNA molecule.
9. The system of claim 1 , wherein the concentration of lipid and dsRNA in the mixture consists of a RNA:lipid charge ratio of 1:2.5 to 1:1.
10. The system of claim 1 , wherein the water-miscible organic solvent is ethanol.
11. The system of claim 1 , wherein the 1 st holding unit and the mixing unit are thermally regulated at a temperature of 35 to 40° C.
12. The system of claim 1 , wherein the aqueous solution in the 2 nd holding unit comprises a buffer at pH 3.5 to pH 6.5.
13. The system of claim 1 , wherein the aqueous buffer in the 3 rd holding unit is at neutral pH.
14. The system of claim 1 , further comprising
a reservoir for mixing RNA and an aqueous buffer to produce the aqueous solution, wherein the reservoir comprises an exit port for delivering the aqueous solution by an 8 th connection from the reservoir to the 2 nd holding unit.
15. The system of claim 1 , wherein the 1 st inlet opening of the mixing unit comprises a multinozzle.
16. The system of claim 15 , wherein the first inlet opening is at or near the top of the mixing unit above the solution.
17. The system of claim 1 , further comprising
a collection bottle for collecting the filter retentate, wherein the collection bottle comprises an inlet opening for receiving the filter retentate by a 9 th connection from the vessel to the collection bottle, and an exit port for delivery of the filter retentate.
18. The system of claim 17 , further comprising
sterile glass vials comprising an opening for receiving the filter retentate from the collection bottle.
19. The system of claim 18 , further comprising a freezer unit capable of cooling the sterile glass vials at 1° C./minute to about −40° C.
20. The system of claim 19 , further comprising a temperature-regulated lyophilizer unit capable of drying frozen bulk product in the glass vials, wherein the lyophilizer unit is capable of regulating a constant low temperature at about −15 to about −35° C., and a constant high temperature at about 15 to about 25° C.
21. The system of claim 14 , wherein the 8 th connection comprises a 7 th pump for delivering the aqueous solution from the reservoir to the 2 nd holding unit, and a 3 rd 0.45 micron or 0.1 micron filter for filtering the aqueous solution.
22. The system of claim 17 , wherein the 9 th connection comprises an 8 th pump for delivering the filter retentate from the vessel to the collection bottle, and a 4 th 0.45 micron or 0.2 micron filter for filtering the filter retentate.